These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38657771)

  • 1. Effects of deep brain stimulation on dopamine D2 receptor binding in patients with treatment-refractory depression.
    Wang F; Xin M; Li X; Li L; Wang C; Dai L; Zheng C; Cao K; Yang X; Ge Q; Li B; Wang T; Zhan S; Li D; Zhang X; Paerhati H; Zhou Y; Liu J; Sun B
    J Affect Disord; 2024 Jul; 356():672-680. PubMed ID: 38657771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parameter-based analysis of clinical efficacy of combined bed nucleus of the stria terminalis-nucleus accumbens deep brain stimulation for treatment-resistant depression.
    Wang T; Dai L; Lai Y; Wang F; Zhang Y; Wang Y; Li D; Zhan S; Bian L; Sun B
    J Neurosurg; 2024 Jun; 140(6):1630-1640. PubMed ID: 38215436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET measurement of changes in D2/D3 dopamine receptor binding in a nonhuman primate during chronic deep brain stimulation of the bed nucleus of the stria terminalis.
    Vandehey NT; Garell PC; Hampel JA; Murali D; Smith EM; Davidson R; Converse AK; Nickles RJ; Christian BT
    J Neurosci Methods; 2009 Jan; 176(2):129-35. PubMed ID: 18824196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep Brain Stimulation of the Medial Forebrain Bundle in a Rodent Model of Depression: Exploring Dopaminergic Mechanisms with Raclopride and Micro-PET.
    Thiele S; Sörensen A; Weis J; Braun F; Meyer PT; Coenen VA; Döbrössy MD
    Stereotact Funct Neurosurg; 2020; 98(1):8-20. PubMed ID: 31982883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased dopamine receptor expression and anti-depressant response following deep brain stimulation of the medial forebrain bundle.
    Dandekar MP; Luse D; Hoffmann C; Cotton P; Peery T; Ruiz C; Hussey C; Giridharan VV; Soares JC; Quevedo J; Fenoy AJ
    J Affect Disord; 2017 Aug; 217():80-88. PubMed ID: 28395208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rostrocaudal gradients of dopamine D2/3 receptor binding in striatal subregions measured with [(11)C]raclopride and high-resolution positron emission tomography.
    Alakurtti K; Johansson JJ; Tuokkola T; Någren K; Rinne JO
    Neuroimage; 2013 Nov; 82():252-9. PubMed ID: 23727314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal neuropsychological outcomes in treatment-resistant depression following bed nucleus of the stria terminalis-area deep brain stimulation: a case review.
    Cassimjee N; van Coller R; Slabbert P; Fletcher L; Vaidyanathan J
    Neurocase; 2018; 24(5-6):231-237. PubMed ID: 30507338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of dopamine receptor 2 binding to pain perception in female fibromyalgia patients with and without depression--A [¹¹C] raclopride PET-study.
    Ledermann K; Jenewein J; Sprott H; Hasler G; Schnyder U; Warnock G; Johayem A; Kollias S; Buck A; Martin-Soelch C
    Eur Neuropsychopharmacol; 2016 Feb; 26(2):320-330. PubMed ID: 26708319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study of bed nucleus of the stria terminalis deep brain stimulation in treatment-resistant depression.
    Fitzgerald PB; Segrave R; Richardson KE; Knox LA; Herring S; Daskalakis ZJ; Bittar RG
    Brain Stimul; 2018; 11(4):921-928. PubMed ID: 29748055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep brain stimulation induces striatal dopamine release in obsessive-compulsive disorder.
    Figee M; de Koning P; Klaassen S; Vulink N; Mantione M; van den Munckhof P; Schuurman R; van Wingen G; van Amelsvoort T; Booij J; Denys D
    Biol Psychiatry; 2014 Apr; 75(8):647-52. PubMed ID: 23938318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo mesolimbic D2/3 receptor binding predicts posttherapeutic clinical responses in restless legs syndrome: a positron emission tomography study.
    Oboshi Y; Ouchi Y; Yagi S; Kono S; Nakai N; Yoshikawa E; Futatsubashi M; Terada T; Kim K; Harada K
    J Cereb Blood Flow Metab; 2012 Apr; 32(4):654-62. PubMed ID: 22234337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of subthalamic nucleus stimulation during exercise on the mesolimbocortical dopaminergic region in Parkinson's disease: a positron emission tomography study.
    Nozaki T; Sugiyama K; Yagi S; Yoshikawa E; Kanno T; Asakawa T; Ito T; Terada T; Namba H; Ouchi Y
    J Cereb Blood Flow Metab; 2013 Mar; 33(3):415-21. PubMed ID: 23211966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D
    Khodaii J; Nomura Y; Chang NHS; Wong DF; Møller A; Gjedde A
    Neurochem Res; 2023 May; 48(5):1517-1530. PubMed ID: 36525123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Striatal dopamine D2/3 receptor-mediated neurotransmission in major depression: Implications for anhedonia, anxiety and treatment response.
    Peciña M; Sikora M; Avery ET; Heffernan J; Peciña S; Mickey BJ; Zubieta JK
    Eur Neuropsychopharmacol; 2017 Oct; 27(10):977-986. PubMed ID: 28870407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression.
    Bewernick BH; Hurlemann R; Matusch A; Kayser S; Grubert C; Hadrysiewicz B; Axmacher N; Lemke M; Cooper-Mahkorn D; Cohen MX; Brockmann H; Lenartz D; Sturm V; Schlaepfer TE
    Biol Psychiatry; 2010 Jan; 67(2):110-6. PubMed ID: 19914605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immediate cerebral metabolic changes induced by discontinuation of deep brain stimulation of subcallosal cingulate gyrus in treatment-resistant depression.
    Martín-Blanco A; Serra-Blasco M; Pérez-Egea R; de Diego-Adeliño J; Carceller-Sindreu M; Puigdemont D; Molet J; Álvarez E; Pérez V; Portella MJ
    J Affect Disord; 2015 Mar; 173():159-62. PubMed ID: 25462411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic exposure to dopamine agonists affects the integrity of striatal D
    Politis M; Wilson H; Wu K; Brooks DJ; Piccini P
    Neuroimage Clin; 2017; 16():455-460. PubMed ID: 28879087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striatal dopamine D2 receptors in medication-naive patients with major depressive disorder as assessed with [11C]raclopride PET.
    Hirvonen J; Karlsson H; Kajander J; Markkula J; Rasi-Hakala H; Någren K; Salminen JK; Hietala J
    Psychopharmacology (Berl); 2008 May; 197(4):581-90. PubMed ID: 18251011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dopamine stabilizer (-)-OSU6162 occupies a subpopulation of striatal dopamine D2/D3 receptors: an [(11)C]raclopride PET study in healthy human subjects.
    Tolboom N; Berendse HW; Leysen JE; Yaqub M; van Berckel BN; Schuit RC; Ponsen MM; Bakker E; Hoetjes NJ; Windhorst AD; Carlsson ML; Lammertsma AA; Carlsson A
    Neuropsychopharmacology; 2015 Jan; 40(2):472-9. PubMed ID: 25248987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similar striatal D2/D3 dopamine receptor availability in adults with Tourette syndrome compared with healthy controls: A [(11) C]-(+)-PHNO and [(11) C]raclopride positron emission tomography imaging study.
    Abi-Jaoude E; Segura B; Obeso I; Cho SS; Houle S; Lang AE; Rusjan P; Sandor P; Strafella AP
    Hum Brain Mapp; 2015 Jul; 36(7):2592-601. PubMed ID: 25788222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.